1Masi AT,Rodnan GP,Medsger TA Jr,et al.Preliminary criteria for the classification of systemic sclerosis (scleroderma)[J].Arthritis Rheum,1980,23(3):581-590.
2Langevizy P,Buskila D,Gladman DD,et al.HLA alleles in systemic sclerosis:association with pulmonary hyertension and outcome[J].Br J Rheumatol,1992,32 (5):609-613.
2Yamane K, Ihn H, Asano Y, et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology,(Oxford), 2000,39 : 1269-1271 .
3Ohtsuka T, Hasegawa A, Nakano A, et al. Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis. Int J Dermatol, 1997,36:116-122.
4Stummvoll GH . Current treatment options in systemic sclerosis(scleroderma). Acta Med Austriaca,2002,29:14 19.
5Seibold JR. Scleroderma. In: Ruddy S, Harris ED, Sledge CB, eds,6th ed. Kelley' s. Textbook of Rheumatology. Philadelphia: Saunders, 2001.1211-1239.
6Langevizy P, Buskila D,Gladman DD, et al. HLA alleles in systemic,sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol, 1992,31:609-613.
7Denton CP,Cailes JB, Phillips GD, et al. Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol, 1997,36:239-243.
8Murata 1, Takenaka K, Yoshinoya S, et al.Clinical evaluation of pulmonary hypertension in systemic sclerosis and related disorders:a Doppler echocardiographic study of 135 Japanese patients. Chest,1997,111:36-43.
9Battle RW, Davitt SM, Buckley LM, et al. Prevalence of pulmonary hypertension in limited and diffuse scleroderma. Chest, 1996, 110:1515-1919.
10Gurubhagavatula I, Palevsky HI. Pulmonary hypertension in systemic autoimmune disease. Rheum Dis Clin North Am, 1997,23:365-394.
